Abstract 6934: Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms

Abstract This study demonstrates an integrated approach for comprehensive characterization of antibody-drug conjugates (ADCs) using complementary bioanalytical platforms. The objective was to evaluate target binding, internalization, and both payload- and Fc-mediated cytotoxic mechanisms to generate a holistic understanding of ADC mode of action.ADC binding affinity and kinetic parameters were characterized by surface plasmon resonance microscopy (SPRm) to assess cell-surface receptor engagement. Internalization was measured in engineered tumor cell lines expressing relevant antigens (e.g., BCMA, CD33) using enzyme-fragment complementation (EFC)-based PathHunter® internalization assays. Functional cytotoxicity was quantified using the KILR® Cytotoxicity platform, providing direct readouts of target-cell death. Fc-effector functions, including antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP), were evaluated using effector cell models to distinguish immune-mediated from payload-driven mechanisms.Here we show characterization data for 2 different ADCs which demonstrated high-affinity binding by SPRm and efficient internalization by PathHunter assays. In KILR assays, the ADC produced a concentration-dependent cytotoxic response distinct from its unconjugated parental antibody. Comparative analysis revealed that payload-mediated killing dominated overall cytotoxicity, while measurable ADCC and ADCP activities reflected retained Fc function. Integration of biophysical and cell-based results provided mechanistic resolution of ADC function at multiple levels. Combining SPRm, PathHunter internalization assays, and KILR cytotoxicity enables comprehensive ADC characterization encompassing binding, uptake, and multi-mechanistic cytotoxicity. This integrated workflow supports discovery, optimization, and lot-release testing by linking molecular properties to functional outcomes, enhancing mechanistic understanding critical for ADC development. Citation Format: Alpana Prasad, Surekha Bonasu, Radhika Venkatnarayanan, Jennifer Lin-Jones, Jane E. Lamerdin, Gaurav Agrawal, Nguyen Ly, Jesus A. Diaz de Leon, Venkatesh Chari. Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6934.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-6934
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 6934: Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms

Alpana Prasad, Venkatesh Chari, Gaurav Agrawal, Jane E. Lamerdin et al.
Cancer Research
HER2/EGFR in Cancer Research
article

Abstract 6934: Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms

Alpana Prasad, Venkatesh Chari, Gaurav Agrawal, Jane E. Lamerdin, Surekha Bonasu, Nguyen Ly, Jesus A. Diaz de Leon, Radhika Venkatnarayanan, Jennifer Lin-Jones
article en

Abstract

Abstract This study demonstrates an integrated approach for comprehensive characterization of antibody-drug conjugates (ADCs) using complementary bioanalytical platforms. The objective was to evaluate target binding, internalization, and both payload- and Fc-mediated cytotoxic mechanisms to generate a holistic understanding of ADC mode of action.ADC binding affinity and kinetic parameters were characterized by surface plasmon resonance microscopy (SPRm) to assess cell-surface receptor engagement. Internalization was measured in engineered tumor cell lines expressing relevant antigens (e.g., BCMA, CD33) using enzyme-fragment complementation (EFC)-based PathHunter® internalization assays. Functional cytotoxicity was quantified using the KILR® Cytotoxicity platform, providing direct readouts of target-cell death. Fc-effector functions, including antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP), were evaluated using effector cell models to distinguish immune-mediated from payload-driven mechanisms.Here we show characterization data for 2 different ADCs which demonstrated high-affinity binding by SPRm and efficient internalization by PathHunter assays. In KILR assays, the ADC produced a concentration-dependent cytotoxic response distinct from its unconjugated parental antibody. Comparative analysis revealed that payload-mediated killing dominated overall cytotoxicity, while measurable ADCC and ADCP activities reflected retained Fc function. Integration of biophysical and cell-based results provided mechanistic resolution of ADC function at multiple levels. Combining SPRm, PathHunter internalization assays, and KILR cytotoxicity enables comprehensive ADC characterization encompassing binding, uptake, and multi-mechanistic cytotoxicity. This integrated workflow supports discovery, optimization, and lot-release testing by linking molecular properties to functional outcomes, enhancing mechanistic understanding critical for ADC development. Citation Format: Alpana Prasad, Surekha Bonasu, Radhika Venkatnarayanan, Jennifer Lin-Jones, Jane E. Lamerdin, Gaurav Agrawal, Nguyen Ly, Jesus A. Diaz de Leon, Venkatesh Chari. Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6934.

Cancer ResearchVol. 86(7_Supplement)
DiscoveRx (United States) (US), Tempe Union High School District (US)
Openalex Percentile: Top 8%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.